See more : Uranium Energy Corp. (UEC) Income Statement Analysis – Financial Results
Complete financial analysis of The Beauty Health Company (SKIN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of The Beauty Health Company, a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
You may be interested
- Galaxy Surfactants Limited (GALAXYSURF.NS) Income Statement Analysis – Financial Results
- Modiv Inc. (MDV-PA) Income Statement Analysis – Financial Results
- Ter Beke NV (TERB.BR) Income Statement Analysis – Financial Results
- Cybele Industries Ltd (CYBELEIND.BO) Income Statement Analysis – Financial Results
- Precision Optics Corporation, Inc. (POCI) Income Statement Analysis – Financial Results
The Beauty Health Company (SKIN)
Industry: Household & Personal Products
Sector: Consumer Defensive
Website: https://www.beautyhealth.com
About The Beauty Health Company
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer's preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 397.99M | 365.88M | 260.09M | 119.09M | 166.62M | 112.31M |
| Cost of Revenue | 242.88M | 115.54M | 78.26M | 51.89M | 60.11M | 39.34M |
| Gross Profit | 155.11M | 250.34M | 181.83M | 67.20M | 106.51M | 72.98M |
| Gross Profit Ratio | 38.97% | 68.42% | 69.91% | 56.43% | 63.92% | 64.98% |
| Research & Development | 10.10M | 8.44M | 8.20M | 3.41M | 4.61M | 2.40M |
| General & Administrative | 131.43M | 106.10M | 98.69M | 30.65M | 26.66M | 17.77M |
| Selling & Marketing | 144.50M | 160.08M | 111.58M | 50.32M | 61.77M | 42.74M |
| SG&A | 275.93M | 266.18M | 210.27M | 80.97M | 88.44M | 60.51M |
| Other Expenses | 0.00 | -1.65M | -51.55M | -47.00K | 535.00K | -9.00K |
| Operating Expenses | 286.03M | 274.62M | 218.47M | 84.38M | 93.05M | 62.92M |
| Cost & Expenses | 528.91M | 390.16M | 296.73M | 136.27M | 153.16M | 102.25M |
| Interest Income | 23.17M | 9.18M | 39.00K | 21.28M | 17.09M | 0.00 |
| Interest Expense | 13.65M | 13.39M | 11.78M | 21.28M | 17.09M | 10.05M |
| Depreciation & Amortization | 34.68M | 22.02M | 21.14M | 14.40M | 13.74M | 11.50M |
| EBITDA | -56.00M | 80.75M | -344.44M | -2.81M | 27.90M | 21.56M |
| EBITDA Ratio | -14.07% | -4.58% | -33.91% | -2.37% | 16.73% | 19.19% |
| Operating Income | -130.92M | -24.28M | -36.64M | -17.18M | 13.46M | 10.06M |
| Operating Income Ratio | -32.89% | -6.64% | -14.09% | -14.43% | 8.08% | 8.96% |
| Total Other Income/Expenses | 29.03M | 71.18M | -337.42M | -21.30M | -16.40M | -10.05M |
| Income Before Tax | -101.89M | 45.03M | -377.35M | -38.48M | -2.94M | 10.00K |
| Income Before Tax Ratio | -25.60% | 12.31% | -145.09% | -32.31% | -1.76% | 0.01% |
| Income Tax Expense | -1.77M | 648.00K | -2.24M | -9.31M | -1.30M | 327.00K |
| Net Income | -100.12M | 44.22M | -375.11M | -29.18M | -1.64M | -317.00K |
| Net Income Ratio | -25.16% | 12.09% | -144.22% | -24.50% | -0.98% | -0.28% |
| EPS | -0.76 | 0.30 | -3.67 | -0.85 | -0.05 | 0.00 |
| EPS Diluted | -0.76 | -0.23 | -3.67 | -0.85 | -0.05 | 0.00 |
| Weighted Avg Shares Out | 131.68M | 147.55M | 102.11M | 34.29M | 32.14M | 125.40M |
| Weighted Avg Shares Out (Dil) | 131.68M | 148.51M | 102.11M | 34.29M | 32.14M | 125.40M |
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of The Beauty Health Company (SKIN) Investors and Encourages Investors to Contact the Firm Before January 16, 2024
NEW YORK--(BUSINESS WIRE)---- $SKIN #classactionlawsuit--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of those who acquired The Beauty Health...
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / December 7, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Beauty Health Company ("BeautyHealth" or "the Company") (NASDAQ:SKIN) for violations of...
FINAL DEADLINE REMINDER: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / December 6, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Beauty Health Company ("BeautyHealth" or "the Company") (NASDAQ:SKIN) for violations of...
SKIN INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that The Beauty Health Company Investors with Substantial Losses Have Opportunity to Lead Case
SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements re: Beauty Health business and prospects, resulting in its stock trading at inflated prices.
BEAUTY HEALTH SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Beauty Health To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $50,000 investing in Beauty Health securities between May 10, 2022 and November 13, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext....
SKIN Investors Have Opportunity to Lead The Beauty Health Company Securities Fraud Lawsuit
LOS ANGELES , Dec. 5, 2023 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against The Beauty Health Company ("Beauty Health" or the "Company")...
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in The Beauty Health Company with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / December 5, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Beauty Health Company ("BeautyHealth" or "the Company") (NASDAQ:SKIN) for violations of...
SHAREHOLDER ALERT: Levi & Korsinsky Notifies The Beauty Health Company(SKIN) Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK , Dec. 5, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in The Beauty Health Company ("Beauty Health" or the "Company") (NASDAQ: SKIN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses...
IMPORTANT DEADLINE NOTICE: The Schall Law Firm Reminds Investors in The Beauty Health Company with Losses In Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / December 4, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Beauty Health Company ("BeautyHealth" or "the Company") (NASDAQ:SKIN) for violations of...
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of The Beauty Health Company of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 16, 2024 - (NASDAQ: SKIN)
NEW YORK , Dec. 4, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of The Beauty Health Company. Shareholders who purchased shares of SKIN during the class period listed are encouraged to contact the firm regarding possible...
Source: https://incomestatements.info
Category: Stock Reports